Compass Therapeutics, Inc. (CMPX)
NASDAQ: CMPX · Real-Time Price · USD
2.335
-0.045 (-1.89%)
Jun 20, 2025, 9:53 AM - Market open
Compass Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2018 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2018 - 2019 |
| Cash & Equivalents | 41.05 | 43.48 | 24.23 | 34.95 | 144.51 | 47.08 | Upgrade
|
| Short-Term Investments | 71.59 | 83.24 | 128.23 | 151.66 | - | - | Upgrade
|
| Cash & Short-Term Investments | 112.64 | 126.72 | 152.46 | 186.61 | 144.51 | 47.08 | Upgrade
|
| Cash Growth | -27.92% | -16.88% | -18.30% | 29.13% | 206.98% | 86.05% | Upgrade
|
| Prepaid Expenses | 11.51 | 6.03 | 1.42 | 8.18 | 2.59 | 3.13 | Upgrade
|
| Total Current Assets | 124.15 | 132.75 | 153.88 | 194.79 | 147.11 | 50.2 | Upgrade
|
| Property, Plant & Equipment | 6.74 | 7.08 | 2.67 | 4.53 | 6.33 | 1.13 | Upgrade
|
| Other Long-Term Assets | 0.57 | 0.57 | 0.32 | 0.32 | 0.32 | 0.58 | Upgrade
|
| Total Assets | 131.45 | 140.4 | 156.88 | 199.65 | 153.76 | 51.91 | Upgrade
|
| Accounts Payable | 1.58 | 2.25 | 4.09 | 3.38 | 0.87 | 1.06 | Upgrade
|
| Accrued Expenses | 13.21 | 6.29 | 2.51 | 11.69 | 8.78 | 1.57 | Upgrade
|
| Current Portion of Long-Term Debt | - | - | - | - | - | 7.47 | Upgrade
|
| Current Portion of Leases | 0.11 | 0.34 | 1.2 | 1.1 | 0.99 | - | Upgrade
|
| Total Current Liabilities | 14.9 | 8.87 | 7.8 | 16.17 | 10.63 | 10.1 | Upgrade
|
| Long-Term Debt | - | - | - | - | - | 1.87 | Upgrade
|
| Long-Term Leases | 6.27 | 6.3 | 0.54 | 1.84 | 3.05 | - | Upgrade
|
| Total Liabilities | 21.17 | 15.17 | 8.34 | 18.01 | 13.68 | 11.97 | Upgrade
|
| Common Stock | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | Upgrade
|
| Additional Paid-In Capital | 491.39 | 489.69 | 463.8 | 454.74 | 373.66 | 191.35 | Upgrade
|
| Retained Earnings | -381.32 | -364.68 | -315.31 | -272.81 | -233.59 | -151.41 | Upgrade
|
| Comprehensive Income & Other | 0.19 | 0.21 | 0.04 | -0.3 | - | - | Upgrade
|
| Total Common Equity | 110.28 | 125.23 | 148.54 | 181.64 | 140.08 | 39.95 | Upgrade
|
| Shareholders' Equity | 110.28 | 125.23 | 148.54 | 181.64 | 140.08 | 39.95 | Upgrade
|
| Total Liabilities & Equity | 131.45 | 140.4 | 156.88 | 199.65 | 153.76 | 51.91 | Upgrade
|
| Total Debt | 6.38 | 6.63 | 1.73 | 2.94 | 4.04 | 9.33 | Upgrade
|
| Net Cash (Debt) | 106.25 | 120.09 | 150.73 | 183.67 | 140.48 | 37.74 | Upgrade
|
| Net Cash Growth | -31.38% | -20.33% | -17.94% | 30.75% | 272.20% | 279.70% | Upgrade
|
| Net Cash Per Share | 0.77 | 0.87 | 1.19 | 1.75 | 2.23 | 1.23 | Upgrade
|
| Filing Date Shares Outstanding | 138.28 | 138.28 | 137.59 | 126.31 | 100.83 | 51.22 | Upgrade
|
| Total Common Shares Outstanding | 138.28 | 137.82 | 127.67 | 126.3 | 100.83 | 51.22 | Upgrade
|
| Working Capital | 109.25 | 123.88 | 146.08 | 178.62 | 136.47 | 40.1 | Upgrade
|
| Book Value Per Share | 0.80 | 0.91 | 1.16 | 1.44 | 1.39 | 0.78 | Upgrade
|
| Tangible Book Value | 110.28 | 125.23 | 148.54 | 181.64 | 140.08 | 39.95 | Upgrade
|
| Tangible Book Value Per Share | 0.80 | 0.91 | 1.16 | 1.44 | 1.39 | 0.78 | Upgrade
|
| Machinery | 4.76 | 4.74 | 5.19 | 5.16 | 5.37 | 5.99 | Upgrade
|
| Leasehold Improvements | 1.61 | 1.61 | 1.61 | 1.61 | 1.53 | 0.9 | Upgrade
|
Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.